China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

Shares of NYSE CPHI opened at $0.20 on Friday. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The company has a 50-day moving average of $0.23 and a 200 day moving average of $0.23. China Pharma has a 12-month low of $0.17 and a 12-month high of $0.72.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.